PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, Induced by Cisplatin Chemotherapy in Patients 1 month to ~ Norgine Pharmaceutica ...

Demant AS (WILLF) reports a 4% revenue growth with strategic brand shifts and AI advancements, while navigating competitive pressures and market headwinds.

Even if Cuban’s no longer calling the shots — or hearing about them ahead of time — the Mavs remain close to his heart.